Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study

Although low sodium intake (<2 g/day) and high potassium intake (>3.5 g/day) are proposed as public health interventions to reduce stroke risk, there is uncertainty about the benefit and feasibility of this combined recommendation on prevention of stroke. METHODS: We obtained random urine samp...

Full description

Bibliographic Details
Published in:American Journal of Hypertension
Main Author: Judge C.; O'Donnell M.J.; Hankey G.J.; Rangarajan S.; Chin S.L.; Rao-Melacini P.; Ferguson J.; Smyth A.; Xavier D.; Lisheng L.; Zhang H.; Lopez-Jaramillo P.; Damasceno A.; Langhorne P.; Rosengren A.; Dans A.L.; Elsayed A.; Avezum A.; Mondo C.; Ryglewicz D.; Czlonkowska A.; Pogosova N.; Weimar C.; Diaz R.; Yusoff K.; Yusufali A.; Oguz A.; Wang X.; Lanas F.; Ogah O.S.; Ogunniyi A.; Iversen H.K.; Malaga G.; Rumboldt Z.; Oveisgharan S.; Al Hussain F.; Yusuf S.
Format: Article
Language:English
Published: Oxford University Press 2021
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105696305&doi=10.1093%2fajh%2fhpaa176&partnerID=40&md5=e86042b7632cc34f57642e60426c162b
id 2-s2.0-85105696305
spelling 2-s2.0-85105696305
Judge C.; O'Donnell M.J.; Hankey G.J.; Rangarajan S.; Chin S.L.; Rao-Melacini P.; Ferguson J.; Smyth A.; Xavier D.; Lisheng L.; Zhang H.; Lopez-Jaramillo P.; Damasceno A.; Langhorne P.; Rosengren A.; Dans A.L.; Elsayed A.; Avezum A.; Mondo C.; Ryglewicz D.; Czlonkowska A.; Pogosova N.; Weimar C.; Diaz R.; Yusoff K.; Yusufali A.; Oguz A.; Wang X.; Lanas F.; Ogah O.S.; Ogunniyi A.; Iversen H.K.; Malaga G.; Rumboldt Z.; Oveisgharan S.; Al Hussain F.; Yusuf S.
Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study
2021
American Journal of Hypertension
34
4
10.1093/ajh/hpaa176
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105696305&doi=10.1093%2fajh%2fhpaa176&partnerID=40&md5=e86042b7632cc34f57642e60426c162b
Although low sodium intake (<2 g/day) and high potassium intake (>3.5 g/day) are proposed as public health interventions to reduce stroke risk, there is uncertainty about the benefit and feasibility of this combined recommendation on prevention of stroke. METHODS: We obtained random urine samples from 9,275 cases of acute first stroke and 9,726 matched controls from 27 countries and estimated the 24-hour sodium and potassium excretion, a surrogate for intake, using the Tanaka formula. Using multivariable conditional logistic regression, we determined the associations of estimated 24-hour urinary sodium and potassium excretion with stroke and its subtypes. RESULTS: Compared with an estimated urinary sodium excretion of 2.8-3.5 g/day (reference), higher (>4.26 g/day) (odds ratio [OR] 1.81; 95% confidence interval [CI], 1.65-2.00) and lower (<2.8 g/day) sodium excretion (OR 1.39; 95% CI, 1.26-1.53) were significantly associated with increased risk of stroke. The stroke risk associated with the highest quartile of sodium intake (sodium excretion >4.26 g/day) was significantly greater (P < 0.001) for intracerebral hemorrhage (ICH) (OR 2.38; 95% CI, 1.93-2.92) than for ischemic stroke (OR 1.67; 95% CI, 1.50-1.87). Urinary potassium was inversely and linearly associated with risk of stroke, and stronger for ischemic stroke than ICH (P = 0.026). In an analysis of combined sodium and potassium excretion, the combination of high potassium intake (>1.58 g/day) and moderate sodium intake (2.8-3.5 g/day) was associated with the lowest risk of stroke. CONCLUSIONS: The association of sodium intake and stroke is J-shaped, with high sodium intake a stronger risk factor for ICH than ischemic stroke. Our data suggest that moderate sodium intake - rather than low sodium intake - combined with high potassium intake may be associated with the lowest risk of stroke and expected to be a more feasible combined dietary target. © 2020 The Author(s) 2020. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd.
Oxford University Press
8957061
English
Article
All Open Access; Hybrid Gold Open Access
author Judge C.; O'Donnell M.J.; Hankey G.J.; Rangarajan S.; Chin S.L.; Rao-Melacini P.; Ferguson J.; Smyth A.; Xavier D.; Lisheng L.; Zhang H.; Lopez-Jaramillo P.; Damasceno A.; Langhorne P.; Rosengren A.; Dans A.L.; Elsayed A.; Avezum A.; Mondo C.; Ryglewicz D.; Czlonkowska A.; Pogosova N.; Weimar C.; Diaz R.; Yusoff K.; Yusufali A.; Oguz A.; Wang X.; Lanas F.; Ogah O.S.; Ogunniyi A.; Iversen H.K.; Malaga G.; Rumboldt Z.; Oveisgharan S.; Al Hussain F.; Yusuf S.
spellingShingle Judge C.; O'Donnell M.J.; Hankey G.J.; Rangarajan S.; Chin S.L.; Rao-Melacini P.; Ferguson J.; Smyth A.; Xavier D.; Lisheng L.; Zhang H.; Lopez-Jaramillo P.; Damasceno A.; Langhorne P.; Rosengren A.; Dans A.L.; Elsayed A.; Avezum A.; Mondo C.; Ryglewicz D.; Czlonkowska A.; Pogosova N.; Weimar C.; Diaz R.; Yusoff K.; Yusufali A.; Oguz A.; Wang X.; Lanas F.; Ogah O.S.; Ogunniyi A.; Iversen H.K.; Malaga G.; Rumboldt Z.; Oveisgharan S.; Al Hussain F.; Yusuf S.
Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study
author_facet Judge C.; O'Donnell M.J.; Hankey G.J.; Rangarajan S.; Chin S.L.; Rao-Melacini P.; Ferguson J.; Smyth A.; Xavier D.; Lisheng L.; Zhang H.; Lopez-Jaramillo P.; Damasceno A.; Langhorne P.; Rosengren A.; Dans A.L.; Elsayed A.; Avezum A.; Mondo C.; Ryglewicz D.; Czlonkowska A.; Pogosova N.; Weimar C.; Diaz R.; Yusoff K.; Yusufali A.; Oguz A.; Wang X.; Lanas F.; Ogah O.S.; Ogunniyi A.; Iversen H.K.; Malaga G.; Rumboldt Z.; Oveisgharan S.; Al Hussain F.; Yusuf S.
author_sort Judge C.; O'Donnell M.J.; Hankey G.J.; Rangarajan S.; Chin S.L.; Rao-Melacini P.; Ferguson J.; Smyth A.; Xavier D.; Lisheng L.; Zhang H.; Lopez-Jaramillo P.; Damasceno A.; Langhorne P.; Rosengren A.; Dans A.L.; Elsayed A.; Avezum A.; Mondo C.; Ryglewicz D.; Czlonkowska A.; Pogosova N.; Weimar C.; Diaz R.; Yusoff K.; Yusufali A.; Oguz A.; Wang X.; Lanas F.; Ogah O.S.; Ogunniyi A.; Iversen H.K.; Malaga G.; Rumboldt Z.; Oveisgharan S.; Al Hussain F.; Yusuf S.
title Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study
title_short Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study
title_full Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study
title_fullStr Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study
title_full_unstemmed Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study
title_sort Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study
publishDate 2021
container_title American Journal of Hypertension
container_volume 34
container_issue 4
doi_str_mv 10.1093/ajh/hpaa176
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105696305&doi=10.1093%2fajh%2fhpaa176&partnerID=40&md5=e86042b7632cc34f57642e60426c162b
description Although low sodium intake (<2 g/day) and high potassium intake (>3.5 g/day) are proposed as public health interventions to reduce stroke risk, there is uncertainty about the benefit and feasibility of this combined recommendation on prevention of stroke. METHODS: We obtained random urine samples from 9,275 cases of acute first stroke and 9,726 matched controls from 27 countries and estimated the 24-hour sodium and potassium excretion, a surrogate for intake, using the Tanaka formula. Using multivariable conditional logistic regression, we determined the associations of estimated 24-hour urinary sodium and potassium excretion with stroke and its subtypes. RESULTS: Compared with an estimated urinary sodium excretion of 2.8-3.5 g/day (reference), higher (>4.26 g/day) (odds ratio [OR] 1.81; 95% confidence interval [CI], 1.65-2.00) and lower (<2.8 g/day) sodium excretion (OR 1.39; 95% CI, 1.26-1.53) were significantly associated with increased risk of stroke. The stroke risk associated with the highest quartile of sodium intake (sodium excretion >4.26 g/day) was significantly greater (P < 0.001) for intracerebral hemorrhage (ICH) (OR 2.38; 95% CI, 1.93-2.92) than for ischemic stroke (OR 1.67; 95% CI, 1.50-1.87). Urinary potassium was inversely and linearly associated with risk of stroke, and stronger for ischemic stroke than ICH (P = 0.026). In an analysis of combined sodium and potassium excretion, the combination of high potassium intake (>1.58 g/day) and moderate sodium intake (2.8-3.5 g/day) was associated with the lowest risk of stroke. CONCLUSIONS: The association of sodium intake and stroke is J-shaped, with high sodium intake a stronger risk factor for ICH than ischemic stroke. Our data suggest that moderate sodium intake - rather than low sodium intake - combined with high potassium intake may be associated with the lowest risk of stroke and expected to be a more feasible combined dietary target. © 2020 The Author(s) 2020. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd.
publisher Oxford University Press
issn 8957061
language English
format Article
accesstype All Open Access; Hybrid Gold Open Access
record_format scopus
collection Scopus
_version_ 1818940560951476224